NanoFlex Power (OPVS) 10-K31 Mar 142013 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2013	Mar. 31, 2014	Jun. 28, 2013
Document And Entity Information [Abstract]	'	'	'
Entity Registrant Name	'NanoFlex Power Corp	'	'
Entity Central Index Key	'0001571636	'	'
Amendment Flag	'false	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Current Fiscal Year End Date	'--12-31	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Common Stock, Shares Outstanding	'	43,385,678	'
Entity Public Float	'	'	$33,000

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS:	'	'
Cash	$197,004	$344,656
Prepaid expenses and other assets	13,645	26,429
Total current assets	210,649	371,085
Property and equipment, net	7,433	4,644
TOTAL ASSETS	218,082	375,729
CURRENT LIABILITIES:	'	'
Accounts payable	689,119	1,003,352
Accrued expenses	676,752	413,828
Accrued payroll	'	854,130
Accrued interest	'	530,502
Short-term debt- related party	100,000	'
Short-term debt, net of unamortized discounts of $-0- and $45,421, respectively	'	4,342,079
Short-term debt, related parties, net unamortized discount of $-0-, respectively	'	500,000
Total current liabilities	1,465,871	7,643,891
TOTAL LIABILITIES	1,465,871	7,643,891
STOCKHOLDERS' DEFICIT:	'	'
Common Stock, 250,000,000 authorized, $0.0001 par value, 42,799,278 and 16,091,909 issued and outstanding, respectively	4,280	1,609
Additional paid in capital	171,010,959	125,754,517
Deficit accumulated during development stage	-172,263,028	-133,024,288
Total stockholders' deficit	-1,247,789	-7,268,162
TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT	$218,082	$375,729

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Balance Sheets [Abstract]	'	'
Short-term debt unamortized discounts	$0	$45,421
Short-term due to related party unamortized discount.	$0	$0
Common Stock, shares authorized	250,000,000	250,000,000
Common Stock, par value per share	$0.00	$0.00
Common Stock, shares issued	42,799,278	16,091,909
Common Stock, Shares, Outstanding	42,799,278	16,091,909

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended		239 Months Ended
Consolidated Statements of Operations (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
OPERATING EXPENSES:	'	'	'
Research and development	$1,390,438	$988,127	$11,457,638
Research and development - stock-based compensation	'	'	3,623,294
Patent application and prosecution fees	2,069,530	1,345,743	12,728,425
Salaries and related expenses	1,900,690	951,411	16,681,654
Stock-based compensation	26,064,190	9,950,226	56,945,272
Selling, general and administrative expenses	1,407,546	622,451	7,541,906
Depreciation and amortization	3,393	1,412	9,279
Total operating expenses	32,835,787	13,869,370	108,987,468
LOSS FROM OPERATIONS	32,835,787	13,869,370	108,987,468
OTHER INCOME (EXPENSES):	'	'	'
Gain on settlement of lawsuit	'	'	268,187
Interest expense	-4,591,153	-4,582,324	-19,229,445
Interest income	'	'	349,162
Loss on extinguishment of debt	-1,811,800	-2,410,506	-44,836,858
Total other expense	-6,402,953	-6,992,830	-63,448,954
LOSS BEFORE INCOME TAX BENEFIT	-39,238,740	-20,862,200	-172,436,422
INCOME TAX BENEFIT	'	'	173,394
NET LOSS	($39,238,740)	($20,862,200)	($172,263,028)
NET LOSS per share (basic and diluted)	($0.59)	($0.52)	'
WEIGHTED AVERAGE COMMON SHARES, OUTSTANDING, BASIC and DILUTED	66,855,209	40,395,528	'

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Stockholders' Deficit (USD $)	Total	Common Stock [Member]	Additional Paid in Capital [Member]	Accumulated Deficit [Member]
Balance at Feb. 07, 1994	$6,000	$120	$5,880	'
Balance, shares at Feb. 07, 1994	'	1,200,000	'	'
Sale of stock, net of offering expenses	16,569,910	169	16,569,741	'
Sale of stock, net of offering expenses, shares	'	1,690,217	'	'
Common shares issued for warrant exercise	1,170,150	60	1,170,090	'
Common shares issued for warrant exercise, share	'	598,125	'	'
Warrants issued for loan modification	2,204,783	'	2,204,783	'
Common shares and warrants issued for debt	3,854,453	20	3,854,433	'
Common shares and warrants issued for debt, shares	'	200,000	'	'
Issuance of common shares and warrants for services	15,404,022	2	15,404,020	'
Issuance of common shares and warrants for services, shares	'	20,000	'	'
Issuance of common shares for license agreements	1,400,000	14	1,399,986	'
Issuance of common shares for license agreements, shares	'	140,000	'	'
Net loss	-44,246,660	'	'	-44,246,660
Balance at Dec. 31, 2008	-3,637,342	385	40,608,933	-44,246,660
Balance, shares at Dec. 31, 2008	'	3,848,342	'	'
Common shares issued for warrant exercise	25,000	1	24,999	'
Common shares issued for warrant exercise, share	'	10,000	'	'
Warrants issued with debt	2,912,792	'	2,912,792	'
Warrants issued for loan modification	11,901,557	'	11,901,557	'
Common shares and warrants issued for debt	60,000	'	60,000	'
Common shares and warrants issued for debt, shares	'	4,000	'	'
Common shares and warrants issued as compensation	1,353,740	'	1,353,740	'
Common shares and warrants issued as compensation, shares	'	200	'	'
Net loss	-19,625,916	'	'	-19,625,916
Balance at Dec. 31, 2009	-7,010,169	386	56,862,021	-63,872,576
Balance, shares at Dec. 31, 2009	'	3,862,542	'	'
Sale of common shares and warrants in PPM	100,000	1	99,999	'
Sale of common shares and warrants in PPM, shares	'	10,000	'	'
Common shares repurchased	-60,000	'	-60,000	'
Common shares repurchased, shares	'	-4,000	'	'
Warrants issued for services	6,538,628	'	6,538,628	'
Warrants issued for services, shares	'	'	'	'
Warrants issued with debt	3,167,513	'	3,167,513	'
Warrants issued for loan modification	24,243,303	'	24,243,303	'
Common shares and warrants issued for debt	4,685,563	46	4,685,517	'
Common shares and warrants issued for debt, shares	'	455,250	'	'
Beneficial conversion feature on converted debt	169,486	'	169,486	'
Net loss	-38,494,396	'	'	-38,494,396
Balance at Dec. 31, 2010	-6,660,072	432	95,706,468	-102,366,972
Balance, shares at Dec. 31, 2010	'	4,323,792	'	'
Sale of common shares and warrants in PPM	2,438,602	27	2,438,575	'
Sale of common shares and warrants in PPM, shares	'	270,000	'	'
Warrants issued for services	1,111,571	'	1,111,571	'
Common shares issued for warrant exercise	1,500	3	1,497	'
Common shares issued for warrant exercise, share	'	30,000	'	'
Common stock issued for cash	1,370,000	27	1,369,973	'
Common shares issued for cash, shares	'	272,000	'	'
Warrants issued with debt	337,693	'	337,693	'
Warrants issued for loan modification	2,110,865	'	2,110,865	'
Common shares issued for Kenyon settlement	114,249	'	114,249	'
Common shares and warrants issued for debt	800,000	8	799,992	'
Common shares and warrants issued for debt, shares	'	80,000	'	'
Common shares issued for warrant exchange with related parties	'	44	-44	'
Common shares issued for warrant exchange with related parties, shares	'	435,030	'	'
Net loss	-9,795,116	'	'	-9,795,116
Balance at Dec. 31, 2011	-8,170,708	541	103,990,839	-112,162,088
Balance, shares at Dec. 31, 2011	'	5,410,822	'	'
Sale of common shares and warrants in PPM	428,500	4	428,496	'
Sale of common shares and warrants in PPM, shares	'	43,250	'	'
Warrants issued for services	9,402,381	300	9,402,081	'
Warrants issued for services, shares	'	2,988,500	'	'
Common shares issued for warrant exercise	1,515,529	128	1,515,401	'
Common shares issued for warrant exercise, share	'	1,282,940	'	'
Common shares issued for warrant exchange	'	46	-46	'
Common shares issued for warrant exchange, shares	'	463,397	'	'
Common shares and warrants issued for debt conversions	289,975	3	289,972	'
Common shares and warrants issued for debt conversions, share	'	31,500	'	'
Common shares issued for loan extensions	2,235,561	36	2,235,525	'
Common shares issued for loan extensions, Share	'	363,500	'	'
Common shares issued with party debt	515,766	20	515,746	'
Common shares issued with party debt, shares	'	198,000	'	'
Common shares issued with related debt	2,206,278	80	2,206,198	'
Common shares issued with related debt, shares	'	800,000	'	'
Common shares issued for debt conversion	4,000,000	440	3,999,560	'
Common shares issued for debt conversion, shares	'	4,400,000	'	'
Common stock issued for cash	100,000	11	99,989	'
Common shares issued for cash, shares	'	110,000	'	'
Warrants issued for loan extensions	155,006	'	155,006	'
Warrants issued with nonconvertible debt	310,732	'	310,732	'
Warrants for issued for warrant exchange	57,173	'	57,173	'
Warrants issued for services	465,533	'	465,533	'
Options issued for services	82,312	'	82,312	'
Stock based compensation	-4,896,143	'	'	'
Return of equity investment	'	'	'	'
Net loss	-20,862,200	'	'	-20,862,200
Balance at Dec. 31, 2012	-7,268,162	1,609	125,754,517	-133,024,288
Balance, shares at Dec. 31, 2012	'	16,091,909	'	'
Sale of common shares and warrants in PPM	532,500	43	532,457	'
Sale of common shares and warrants in PPM, shares	'	426,000	'	'
Common shares issued for warrant exercise	176,819	6	176,813	'
Common shares issued for warrant exercise, share	'	60,070	'	'
Common shares and warrants issued for debt conversions, share	115,500	'	'	'
Common shares issued for loan extensions	1,758,900	29	1,758,871	'
Common shares issued for loan extensions, Share	'	286,000	'	'
Common shares issued for debt conversion	282,900	5	282,895	'
Common shares issued for debt conversion, shares	'	46,000	'	'
Common stock issued for cash	1,050,000	116	1,049,884	'
Common shares issued for cash, shares	'	1,155,000	'	'
Common shares issued for services	25,971,940	286	25,971,654	'
Common shares issued for services, share	15,000	2,858,811	'	'
Common shares issued to debt holders for additional interest	1,067,345	17	1,067,328	'
Common shares issued to debt holders for additional interest, share	'	173,552	'	'
Common shares issued for default penalty interest	2,214,000	36	2,213,964	'
Common shares issued for default penalty interest, share	'	360,000	'	'
Common shares issued to warrant holders for additional interest	733,695	12	733,683	'
Common shares issued to warrant holders for additional interest, share	'	119,300	'	'
Common shares issued for consulting services	92,250	'	92,250	'
Common shares issued for consulting services, share	'	15,000	'	'
Common shares issued for forgiveness of debt	162,915	12	162,903	'
Common shares issued for forgiveness of debt, share	'	115,500	'	'
Reverse merger adjustment	5,149	966	4,183	'
Reverse merger adjustment, share	'	9,658,936	'	'
Common shares issued for automatic conversion of debt due to merger	11,433,200	1,143	11,432,057	'
Common shares issued for automatic conversion of debt due to merger, share	'	11,433,200	'	'
Return of equity investment	-222,500	'	-222,500	'
Net loss	-39,238,740	'	'	-39,238,740
Balance at Dec. 31, 2013	($1,247,789)	$4,280	$171,010,959	($172,263,028)
Balance, shares at Dec. 31, 2013	'	42,799,278	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended		239 Months Ended
Consolidated Statements of Cash Flows (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net loss	($39,238,740)	($20,862,200)	($172,263,028)
Adjustments to reconcile net loss to net cash used in operating activities	'	'	'
Common shares issued for license agreements	'	'	1,400,000
Warrants issued for legal settlement	'	'	-268,187
Depreciation expense	3,393	1,412	28,157
Amortization of debt discounts	45,421	3,653,530	12,175,705
New warrants issued to substitute old warrants	'	57,173	57,173
Stock-based compensation	26,064,190	9,950,226	60,422,377
Interest expense from convertible debt converted to warrants	'	'	133,063
Interest expense from related party interest converted to common shares	57,915	'	57,915
Interest expense from additional common shares issued	4,015,040	2,410,506	4,015,040
Loss on extinguishment of debt	1,811,800	2,410,506	44,836,858
Return of equity investment	-222,500	'	-222,500
Changes in operating assets and liabilities:	'	'	'
Prepaid expenses and other current assets	12,784	-12,732	-13,645
Accounts payable and accrued expenses	-1,330,941	-409,757	1,853,307
Net cash used in operating activities	-8,781,638	-5,211,842	-47,787,765
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Purchase of fixed assets	-6,182	-2,118	-35,590
Common shares issued in reverse merger, net	5,149	'	5,149
Net cash provided by (used in) investing activities	-1,033	-2,118	-30,441
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Proceeds from exercise of warrants	176,819	1,515,529	2,888,998
Proceeds from sale of common shares and warrants	532,500	428,500	21,445,512
Proceeds from sale of common shares- related party	1,050,000	100,000	1,150,000
Borrowings on debt	'	2,300,000	17,037,500
Borrowings on related party debt	240,000	2,130,000	4,445,000
Borrowings on convertible debt- related party	6,800,000	'	7,592,500
Borrowing on convertible debt	2,124,500	'	2,124,500
Principal repayments on debt	-1,725,000	-300,000	-7,475,000
Principal repayments on related party debt	-563,800	-630,000	-1,193,800
Net cash provided by Financing activities	8,635,019	5,544,029	48,015,210
NET INCREASE (DECREASE) IN CASH	-147,652	330,069	197,004
CASH AT BEGINNING OF YEAR	344,656	14,587	'
CASH AT END OF PERIOD	197,004	344,656	197,004
SUPPLEMENTAL CASH FLOW INFORMATION	'	'	'
Cash paid for interest	753,558	535,261	2,601,625
Cash paid for tax	'	'	'
NON-CASH INVESTING AND FINANCING ACTIVITIES	'	'	'
Warrants and common shares issued with debt	'	771,377	7,244,532
Common shares issued with related party debt	'	2,206,278	2,206,278
Warrants and common shares issued for debt	230,000	250,000	9,766,953
Common shares issued for forgiveness of related party debt	105,000	4,000,000	4,105,000
Common shares repurchased with debt	'	'	60,000
Warrants issued for legal settlement	'	'	114,249
Common shares issued for conversion of convertible debt upon merger	11,433,200	'	11,433,200
Beneficial conversion feature on converted debt	'	'	$169,486

Background_Basis_of_Presentati

Background, Basis of Presentation	12 Months Ended
	Dec. 31, 2013
Background, Basis of Presentation [Abstract]	'
BACKGROUND, BASIS OF PRESENTATION	'
	1. BACKGROUND, BASIS OF PRESENTATION:

	Background

	Global Photonic Energy Corporation was incorporated in Pennsylvania on February 7, 1994. The Company is a development stage company organized to fund, develop and commercialize photonic energy conversion technologies utilizing organic semiconductor-based solar cells. The Company intends to enter into licensing arrangements and other strategic alliances for the development, manufacture and marketing of products utilizing this technology.

	The technology is targeted at certain broad applications including 1) mobile electronic device power, 2) electric vehicle (EV) charging or “power paint”, 3) semi-transparent solar power generating windows or glazing and 4) traditional off-grid and grid-connected solar power generation. Laboratory feasibility prototypes have been developed that successfully demonstrate key building block principles for these technology application areas.

	Universal Technology Systems Corp. (“UTCH”) (“we”, “our” or the “Company”) was incorporated in Florida on January 28, 2013.

	On September 24, 2013, Universal Technology Systems Corp. (“UTCH”) entered into a stock exchange agreement with Global Photonic Energy Corporation (“GPEC”) and the shareholders of UTCH. Pursuant to the Share Exchange Agreement, UTCH issued 15,500,640 shares of its common stock, representing no less than 80% of the total issued and outstanding common stock of UTCH, to the shareholders of GPEC in exchange for 100% of the issued and outstanding capital stock of GPEC. As a result of this transaction, GPEC became UTCH wholly-owned subsidiary, and UTCH acquired the business and operations of GPEC.

	For accounting purposes, this transaction was accounted for as a reverse merger and has been treated as a recapitalization of UTCH, where GPEC is considered the accounting acquirer, and the financial statements of the accounting acquirer became the financial statements of the registrant. The Company did not recognize goodwill or any intangible assets in connection with the transaction. Additionally all assets and liabilities of the Company were transferred to GPEC .The historical consolidated financial statements include the operations of the accounting acquirer for all periods presented.

	At the Closing, there were GPEC common shares of 77,503,198 , warrants of 9,586,416, options of 525,000 and 5,255 series A Preferred convertible stock issued and outstanding. As part of the Merger, GPEC shareholders of the Company as of September 24, 2013 received 1 common share of UTCH, Inc. for each 5 common shares, warrants, options and 1,100 common shares for each series A Preferred convertible stock owned of GPEC.

	Pursuant to the terms and conditions of the issued and outstanding 5,255 Series A Preferred of GPEC and the GPEC Bridge Notes of $11,433,200, UTCH issued to the holders of Series A Preferred: (i) a total of 5,780,500 shares of UTCH Common Stock and (ii) warrants to purchase a total of 5,780,500 shares of UTCH Common Stock and also issued to holders of the GPEC Bridge Notes: (i) a total of 11,433,200 shares of UTCH Common Stock and (ii) warrants to purchase a total of 11,433,200 shares of UTCH Common Stock, as a result of the automatic conversion of such Series A Preferred and GPEC Bridge Notes.

	In addition, as of the Closing Date, there were issued and outstanding: (i) warrants to purchase an aggregate of 1,917,283 shares of GPEC Common Stock (“GPEC Warrants”) and (ii) options to purchase an aggregate of 105,000 shares of GPEC Common Stock (“GPEC Options).

	Sponsored Research Agreement -

	Research and development of the Technology is being conducted at the University of Southern California (“USC”) and, on a subcontractor basis, at the University of Michigan, beginning 2006 and currently under a 5-year Sponsored Research Agreement dated May 1, 2009. During this period, the Company has agreed to pay USC up to $6,338,341 for work to be performed. On December 20, 2013, the Company entered into a Research Agreement with USC (“2013 Research Agreement”) to amend and replace the 2009 Research Agreement to continue the sponsored research at USC and Michigan from February 1, 2014 through January 31, 2021. On the same day, they have also entered into a Third Amendment to the License Agreement which renews and extends the License Agreement by and between USC, Michigan, Princeton and GPEC (“Third Amendment to License Agreement”). GPEC assigned to the Company and the Company assumed all the rights and obligations under both the 2013 Research Agreement and the Third Amendment to License Agreement. The Company expensed $4,080,008 from May 1, 2009 through December 31, 2013.

	License Agreement -

	The Company possesses an exclusive worldwide license and the right to sublicense any and all inventions and intellectual property resulting from the Company’s research agreements. Royalties due under the agreement are 3% of revenues from sublicensing technology and 23% of revenues from any patent rights lawsuit proceeds. Minimum royalties are as follows:

	2019 and thereafter
	Year ended December 31, 2014	$	25,000
	2015		40,000
	2016		50,000
	2017		65,000
	2018		75,000
		100,000

Going_Concern

Going Concern	12 Months Ended
Going Concern	Dec. 31, 2013
Going Concern [Abstract]	'
GOING CONCERN	'
	2. GOING CONCERN

	The Company has not generated revenues to date. The Company has a working capital deficit of $1,255,222 and an accumulated deficit of $172,263,028 as of December 31, 2013. The ability of the Company to continue as a going concern is dependent on raising capital to fund ongoing operations and carry out its business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Cash and Cash Equivalents

	For purposes of the statement of cash flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.

	Principles of consolidation

	The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Equity investments in which we exercise significant influence, but do not control and are not the primary beneficiary, are accounted for using the equity method of accounting. Investments in which we do not exercise significant influence over the investee are accounted for using the cost method of accounting. Intercompany transactions are eliminated.

	Property and Equipment

	Property and equipment are stated at cost. Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets. Estimated useful lives range from three to eight years.

	Impairment of long-lived assets - The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Fair value is estimated based upon either discounted cash flow analysis or estimated salvage value

	Stock-Based Compensation

	We account for stock based compensation in accordance with FASB ASC 718 which requires companies to measure the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. For stock-based awards granted on or after January 1, 2006, stock-based compensation expense is recognized on a straight-line basis over the requisite service period. In prior years, we accounted for stock-based awards under APB No. 25, “Accounting for Stock Issued to Employees.” We account for non-employee share-based awards in accordance with FASB ASC 505-50.

	Use of Estimates

	The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect certain reported amounts and disclosures in the financial statements and accompanying notes. The significant estimates relate useful lives of software licenses, valuation of beneficial conversion feature on convertible debts, valuation of warrants and stock options, and valuation allowance for deferred income taxes. Actual results could differ from those estimates.

	Credit Risk

	Cash is maintained in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk on cash.

	Development Stage Company

	The Company is a development stage company as defined by ASC 915, Accounting and Reporting by Development Stage Entities. The Company is devoting substantially all of its present efforts to establishing a new business. All losses accumulated since inception have been considered as part of the Company’s development stage activities.

	Research and Development

	Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life, or written off if a product is abandoned. At December 31, 2013 and 2012, the Company had no deferred development costs.

	Fair Value of Financial Instruments

	The carrying value of short-term financial instruments, including cash, accounts receivable, accounts payable and accrued expenses, and short-term borrowings approximate fair value due to the relatively short period to maturity for these instruments. The long-term borrowings approximate fair value since the related rates of interest approximates current market rates.

	Income Taxes

	Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse.

	We have net operating loss carry-forwards available to reduce future taxable income. Future tax benefits for these net operating loss carry-forwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that we will not realize a future tax benefit, a valuation allowance is established.

	New Accounting Pronouncements

	No recent accounting pronouncements are expected to have a material impact on the Company’s financial statements.

Related_Party_Convertible_Note

Related Party Convertible Notes Payable	12 Months Ended
Related Party Convertible Notes Payable	Dec. 31, 2013
Related Party Convertible Notes Payable [Abstract]	'
RELATED PARTY CONVERTIBLE NOTES PAYABLE	'
	4. RELATED PARTY CONVERTIBLE NOTES PAYABLE

	During 2013, the Company borrowed $6,800,000 from a majority shareholder. These loans were convertible short term note agreements. The notes were unsecured, bore interest at 5% per annum and had a maturity date of December 31, 2013. The notes converted upon the completion of the reverse merger and converted into units of UTCH. Each unit consisted of (i) one share of the Common Stock and (ii) one warrant to purchase one share of the Common Stock. The conversion price was $1 per unit. The warrant may be exercised at a purchase price of $2.50 per share. The holder has a period to exercise of 5 years from the date of issuance. The Company analyzed the conversion options in the Convertible Promissory notes for derivative accounting consideration under ASC 815, Derivative and Hedging, and determines that the transactions do not qualify for derivative treatment. Further, the Company determined that there is no discount to be recognized under accounting for beneficial conversion feature as these notes were automatically converted into the Public Company stock upon completion of a merger which closed on September 24, 2013. On September 24, 2013, the Company issued 6,800,000 common shares and 6,800,000 warrants for the conversion of these notes.

	The Company converted outstanding accrued interest of $105,000 due to a majority shareholder, into 115,500 common shares. The relative fair value of these shares was determined to be $57,915 and it was recorded as a debt discount. The full discount was amortized to interest expense during 2013.

	In addition, the Company borrowed $240,000 in the form of short term related party notes and repaid $563,800 and converted $76,200 into common shares upon complete of the reverse merger (see note 1) during 2013. As of December 31, 2013, the balance due is $100,000.

	On September 24, 2013, the Company issued 76,200 common shares and 76,200 warrants for the conversion of these notes.

	During 2012, the Company borrowed $2,130,000 from a majority shareholder. These loans were unsecured, bore interest at 5% per annum and originally matured December 22, 2012. In connection with the loans, on January 31, 2012, the note holder was guaranteed 4,000,000 common shares. The relative fair value of these shares was determined to be $2,206,278 and it was recorded as a debt discount. The full discount was amortized to interest expense during 2012. On May 23, 2012, the Company entered into an amended debt agreement with the shareholder whereby all accrued interest was paid in cash and the interest rate of 5% was replaced with a fixed amount of interest of $10,000 for all existing debt and any future debt. The Company evaluated the amendment under FASB ASC 470-50 and determined that the modification was not substantial. In 2012, the Company made cash payments on these notes totaling $630,000 and the remaining $4,000,000 was converted to common shares (see Note 8). As of December 31, 2012, the Company has a balance of $500,000 net discount due to related parties.

	Additionally in 2012, the Company recorded amortization of debt discount on related party debt totaling $2,239,020

Convertible_Notes_Payable

Convertible Notes Payable	12 Months Ended
Convertible Notes Payable	Dec. 31, 2013
Convertible Notes Payable [Abstract]	'
CONVERTIBLE NOTES PAYABLE	'
	5. CONVERTIBLE NOTES PAYABLE

	During 2013, the Company modified $2,432,500 of its outstanding short term debt whereby the notes become convertible. Additionally, from July 1, 2013 through September 24, 2013, the Company borrowed $2,124,500 from private investors. The notes were unsecured, bear interest at 5% per annum and had a maturity date of December 31, 2013. The notes converted upon the completion of the reverse merger and converted into units of UTCH. Each unit consists of (i) one share of the Common Stock and (ii) one warrant to purchase one share of the Common Stock. The conversion price is $1 per unit. The warrant may be exercised at a purchase price of $2.50 per share. The holder has a period to exercise of 5 years from the date of issuance. The Company analyzed the conversion options in the Convertible Promissory notes for derivative accounting consideration under ASC 815, Derivative and Hedging, and determines that the transactions do not qualify for derivative treatment. Further, the Company determined that there is no discount to be recognized under accounting for beneficial conversion feature as these notes were automatically converted into the Public Company stock upon completion of a merger which closed on September 24, 2013.

	On September 24, 2013, the Company issued 4,557,000 common shares and 4,557,000 warrants for the conversion of these notes.

Notes_Payable

Notes Payable	12 Months Ended
	Dec. 31, 2013
Notes Payable [Abstract]	'
NOTES PAYABLE	'
	6. NOTES PAYABLE

	During 2013, the Company repaid an aggregate of $1,725,000 to the third party creditors. In addition, an aggregate of $230,000 of debt was converted into 46,000 common shares. As the debt was not originally convertible, the issuance of the shares to settle the debt was determined to be debt extinguishment. The fair value of the common shares was determined to be $282,900 and therefore a loss on debt extinguishment was recognized of $52,900.

	During 2013, the maturity date on an aggregate of $1,400,000 of outstanding debt was extended an additional 3 or 4 months. In connection with the extensions, the Company issued 286,000 common shares. The Company evaluated the modifications under ASC 470-50 determined that the modifications were substantial and the revised terms constituted debt extinguishments. The fair value of the common shares was determined to be $1,758,900, and accounted for as a loss on the extinguishment of debt. These notes were converted into the convertible notes see Note 5 and then converted into equity.

	During 2013, the aggregate amortization of other debt discounts totaled $45,421. These discounts were originally recorded during 2012, 2011 and 2010. As of December 31, 2013, there is no unamortized debt discount remaining.

	During 2012, the Company borrowed $2,300,000 at interest rates ranging from 5% - 45% per annum. In connection with these borrowings, the Company issued 65,500 warrants and 198,000 common shares. The warrants are exercisable at prices ranging from $0.01 - $2.40, vested immediately and have a term of 5 years. The relative value calculated on the warrants issued was $310,732 and has been recorded as a note discount. The warrants were fully amortized during the year. In addition, the Company issued 198,000 common shares with a relative value of $515,802. The relative value was recorded as a discount on the notes and amortized over the life of the notes. The amortization of debt discount related to the common shares for 2012 is $470,433, leaving an unamortized discount of $45,369.

	During 2012, a total of $270,000 in notes were converted into a total of 31,500 common shares and 25,000 warrants. The Company recognized a loss on debt extinguishment of $19,975 in conjunction with these conversions.

	Debt Extensions -

	At December 31, 2012, the maturity date on an aggregate of $3,325,000 of outstanding debt was extended an additional 3 to 6 months. In connection with the extensions, the Company issued 363,500 common shares and 100,000 warrants. The warrants are exercisable at $12.00, vest immediately and have a term of 5 years. The Company evaluated the modifications under FASB ASC 470-50 determined that the modifications were substantial and the revised terms constituted debt extinguishments. The fair value of the common shares was determined to be $2,235,525 and the fair value of the warrants was determined to be $155,006 resulting in a total loss on the extinguishment of debt due to debt extensions of $2,390,531.

	The fair values of the warrants were calculated using the Black-Scholes option-pricing model with the following assumptions:

	Assumption	2012
	Expected Volatility		98%-111	%
	Expected term (years)		4-Feb
	Risk-free interest rate		0.74%-2.01	%

Stock_Options_and_Warrants

Stock Options and Warrants	12 Months Ended
Stock Options and Warrants	Dec. 31, 2013
Stock Options and Warrants [Abstract]	'
STOCK OPTIONS AND WARRANTS	'
	7. STOCK OPTIONS AND WARRANTS

	2000 Stock Option Plan

	On April 28, 2000, the Board of Directors adopted the 2000 Stock Option Plan. Under the Plan, the Company may grant incentive stock options to employees and non-qualified stock options to employees, non-employee directors and/or consultants. The Plan provides for the granting of a maximum of 2,000,000 options to purchase common stock. The ISO exercise price per share may not be less than the fair market value of a share on the date the option is granted. The maximum term of the options may not exceed ten years.

	A summary of stock option activity during the year ended December 31, 2013 and 2012 is as follows:

		Options			Weighted Average
		Options			Exercise Price
	Outstanding at December 31, 2011		186,000		$	10.6
	Granted		15,000			10
	Cancelled		(64,000	)		10.05
	Outstanding at December 31, 2012		137,000		$	9.7
	Granted		-			-
	Exercised		-			-
	Cancelled		(32,000	)		10.06
	Forfeited		-			-
	Outstanding at December 31, 2013		105,000		$	11.03
	Exercisable		105,000		$	11.03

	The weighted average remaining contractual life of options outstanding as of December 31, 2013 and 2012, was approximately 2.60 and 1.94 years, respectively. The exercise price of these options range from $10.00 to $15.00 and the intrinsic value of the options as of December 31, 2013 and 2012 is $0.00, respectively.

	A total of 15,000 options were issued for services in 2012. The exercise price of the options is $10.00. The term of the options is 10 years. These options are fully vested and non-forfeitable upon issuance, accordingly the total fair value of $82,312 was expensed in 2012

	A summary of warrant activity during the year ended December 31, 2013 and 2012 is as follows:

					Weighted Average
		Warrants			Exercise Price
	Outstanding at December 31, 2011		7,033,392			13.6
	Granted		665,150			9.55
	Exercised		(1,282,940	)		4.5
	Cancelled		(3,923,518	)		15.5
	Forfeited		(425,000	)		15.2
	Outstanding at December 31, 2012		2,007,083			13.9
	Granted		17,639,700			0.4
	Exercised		(65,050	)		13.26
	Cancelled		(24,750	)		5.56
	Forfeited		-			-
	Outstanding at December 30, 2013		19,556,983		$	3.6
	Exercisable		19,556,983		$	3.6

	The weighted average remaining contractual life for warrants outstanding as of December 31, 2013 and 2012 was approximately 4.72 and 14 years, respectively. The exercise price of these warrants ranges from $0.05 to $17.50 and the intrinsic value of the warrants December 31, 2013 and 2012, is $-0-, respectively.

	During 2013, an aggregate of 65,050 warrants were exercised for cash proceeds of $176,819.

	A total of 83,400 warrants were issued for services in 2012. The exercise price of the warrants ranges from $5.00 to $12.00. The terms of the warrants ranges from 5-10 years. These warrants are fully vested and non-forfeitable upon issuance, accordingly the total fair value of $465,533 was expensed in 2012.

	During 2012, 23,400 warrants were granted in exchange for 21,060 previously granted warrants. The warrants are exercisable at $12.00, vest immediately and have a term of 5 years. The Company determined the fair value of the warrants on the grant date and the fair value of the cancelled warrants and recorded an expense for the incremental increase in the fair value of the equity award. The incremental increase in the fair value that was expensed totaled $57,173.

	During 2012, the Company canceled a total of 3,053,958 warrants in exchange for 463,397 common shares. This transaction qualified as a modification of a previous award. The change in fair value due to the modification was a decrease; thus, there was no additional expense recorded

Common_Stock

Common Stock	12 Months Ended
Common Stock	Dec. 31, 2013
Common Stock [Abstract]	'
COMMON STOCK	'
	8. COMMON STOCK

	As of December 31, 2013, an aggregate of 60,070 common shares were issued for the exercise of warrants for cash proceeds of $176,819. (see Note 7)

	During 2013, the Company issued an aggregate of 2,858,811 common shares to officers as compensation. The shares are fully vested. The fair value of the shares was determined to be $25,971,940 and was recognized as stock-based compensation.

	The Company 286,000 common shares were issued for loan extensions valued at $1,758,900.

	During 2013, the Company issued an aggregate of 173,552 common shares to note holders as additional interest. The fair value of the shares was determined to be $1,067,345 and was recognized as interest expense.

	During 2013, the Company issued 360,000 common shares to a third party note holder. These shares were issued in accordance to the default terms of the 2010 and 2011 notes. The fair value of the shares was determined to be $2,214,000 and was recognized as interest expense.

	The Company issued an aggregate of 119,300 common shares to certain warrant holders as additional interest. The fair value of the shares was determined to be $733,695 and was recognized as interest expense during the year ending December 31, 2013.

	During 2013, the Company issued 15,000 common shares for consulting services. The shares vest immediately. The fair value of the shares was determined to be $92,250 and was recognized as stock based compensation during the nine months ended December30, 2013

	The Company issued 46,000 common shares were issued for the conversion of short term debt valued at $282,900.

	As of December 31, 2013, the Company issued 1,155,000 common shares sold for cash to a majority shareholder for proceeds of 1,050,000.

	As of December 31, 2013, a majority shareholder converted $105,000 of the interest due to him into 115,500 common shares valued at $162,915.

	Prior to the closing of the shares exchange agreement, UTCH had 12,000,000 common shares outstanding. On September 22, 2013, UTCH cancelled 9,000,000 shares of UTCH and sold 5,049,113 common shares to GPEC officers for cash proceeds of $5,149. Effective September 22, 2013, UTCH
	affected a 1.2-for-1 forward split of the outstanding common stock of the Company, par value $.0001. Authorized and issued common stock increased from 8,049,113 to 9,658,936. All references to UTCH common stock have been retroactively restated to reflect the effect of the forward split. Immediately prior to the closing of the agreement, UTCH had 9,658,936 shares of common stock issued and outstanding.

	During 2013, the Company paid common share holders $130,000 for the return of equity investment of $225,000. The Company recorded the cash paid and return of equity as additional interest expense. The common shares will be cancelled when returned. The common shares have not been returned as of December 31, 2013.

	During 2013, Global sold 426,000 units at $1.25 unit for $532,500. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.

	During 2012, Global sold 43,250 units at $10.00 per unit for $428,500. Each unit consisted of one common share and one warrant. The warrants are exercisable at $12.00, vest immediately and have a term of 5 years. The relative fair value of the warrants was determined to be $146,231.

	During 2012, the Company issued an aggregate of 2,988,500 to officers as compensation of which 2,110,000 have the following vesting terms, 1/4 immediately upon issuance, 1/4 will be released upon one year from the effective date, and 1/4 will be released upon two years, the last 1/4 will be released after three years completion from the effective date. The other 878,500 shares vest immediately. The fair value of the shares was determined to be $9,402,381 and was recognized as stock-based compensation in 2012.

	During 2012, 1,282,940 common shares were issued for the exercise of warrants for cash proceeds of $1,515,529. (see note 7)

	During 2012, the Company issued an aggregate of 463,397 common shares and 74,400 warrants in exchange for 3,053,958 previously granted warrants (see Note 7).

	During 2012, 31,500 common shares were issued for the conversion of debt (see Note 5), 363,500 common shares were issued for loan extensions (see Note 5), 198,000 common shares were issued with debt (see Note 5) and 800,000 common shares were issued with related party debt (see Note 4).

	During 2012, the Company issued 4,400,000 common shares to related party for the conversion of note payable (see note 4) and issued 110,000 common shares at $0.91 per share or proceeds of $100,000.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	9. COMMITMENTS AND CONTINGENCIES

	Under the 2013 Research Agreement with USC, the Company is obligated to make certain payments to USC based on work performed by USC under that agreement, and by Michigan under its subcontractor agreement with USC. (See Note 1)

	Under the terms of the 2013 Amended License Agreement, the Company is required to make minimum royalty payments to Princeton. (See Note 1)

	The Company has agreements with three executive officers which provide for certain cash and other benefits upon termination of employment of the officer in connection with a change in control of the Company. Each executive is entitled to a lump-sum cash payment equal to three times the sum of the average annual base salary also they are entitled to a cash bonus.

	In November 2013, the Company entered into a 60-month lease agreement for its corporation facility in Arizona. As of December 31, 2013 the Company paid $3,689 in rent connection with this lease agreement.

	Future minimum lease payments are as follows:

	2014	$	82,899
	2015	$	85,256
	2016	$	87,614
	2017	$	89,971
	2018	$	84,634

	During 2013 and 2012 the Company rented office space in Idaho under month-to–month leases. Total rent expense during 2013 and 2012 was $4,476 and $15,608, respectively. The Company no longer rents space in Idaho.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]	'
Income Taxes	'
	10. INCOME TAXES

	The Company has incurred losses since inception. As of December 31, 2012, the Company has net operating loss carry-forwards of approximately $51,000,000 that begin to expire in 2016. The components of the deferred tax assets consist of the following:

		December 31,
		2013			2012
	Net operating losses	$	17,300,000		$	14,700,000
	Less: valuation allowance		(17,300,000	)		(14,700,000	)
	Net deferred tax assets	$	-		$	-

	A valuation allowance was established for all the net deferred tax assets because realization is not assured.

Subsequent_Events

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2013
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	11. SUBSEQUENT EVENTS

	During 2014, we sold 112 units at $1.25 unit for $140,000. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Cash and Cash Equivalents	'
	Cash and Cash Equivalents

	For purposes of the statement of cash flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
Principles of consolidation	'
	Principles of consolidation

	The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Equity investments in which we exercise significant influence, but do not control and are not the primary beneficiary, are accounted for using the equity method of accounting. Investments in which we do not exercise significant influence over the investee are accounted for using the cost method of accounting. Intercompany transactions are eliminated.

Property and Equipment	'
	Property and Equipment

	Property and equipment are stated at cost. Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets. Estimated useful lives range from three to eight years.

Impairment of long-lived assets	'
	Impairment of long-lived assets - The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Fair value is estimated based upon either discounted cash flow analysis or estimated salvage value

Stock-Based Compensation	'
	Stock-Based Compensation

	We account for stock based compensation in accordance with FASB ASC 718 which requires companies to measure the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. For stock-based awards granted on or after January 1, 2006, stock-based compensation expense is recognized on a straight-line basis over the requisite service period. In prior years, we accounted for stock-based awards under APB No. 25, “Accounting for Stock Issued to Employees.” We account for non-employee share-based awards in accordance with FASB ASC 505-50.
Use of Estimates	'
	Use of Estimates

	The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect certain reported amounts and disclosures in the financial statements and accompanying notes. The significant estimates relate useful lives of software licenses, valuation of beneficial conversion feature on convertible debts, valuation of warrants and stock options, and valuation allowance for deferred income taxes. Actual results could differ from those estimates.
Credit Risk	'
	Credit Risk

	Cash is maintained in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk on cash.

Development Stage Company	'
	Development Stage Company

	The Company is a development stage company as defined by ASC 915, Accounting and Reporting by Development Stage Entities. The Company is devoting substantially all of its present efforts to establishing a new business. All losses accumulated since inception have been considered as part of the Company’s development stage activities.

Research and Development	'
	Research and Development

	Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life, or written off if a product is abandoned. At December 31, 2013 and 2012, the Company had no deferred development costs.

Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments

	The carrying value of short-term financial instruments, including cash, accounts receivable, accounts payable and accrued expenses, and short-term borrowings approximate fair value due to the relatively short period to maturity for these instruments. The long-term borrowings approximate fair value since the related rates of interest approximates current market rates.

Income Taxes	'
	Income Taxes

	Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse.

	We have net operating loss carry-forwards available to reduce future taxable income. Future tax benefits for these net operating loss carry-forwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that we will not realize a future tax benefit, a valuation allowance is established.

New Accounting Pronouncements	'
	New Accounting Pronouncements

	No recent accounting pronouncements are expected to have a material impact on the Company’s financial statements.

Background_Basis_of_Presentati1

Background, Basis of Presentation (Tables)	12 Months Ended
Background, Basis of Presentation (Tables)	Dec. 31, 2013
Background, Basis of Presentation [Abstract]	'
Summary of royalty revenue	'
	Year ended December 31, 2014	$	25,000
	2015		40,000
	2016		50,000
	2017		65,000
	2018		75,000
	2019 and thereafter		100,000

Notes_Payable_Tables

Notes Payable (Tables)	12 Months Ended
Notes Payable (Tables)	Dec. 31, 2013
Notes Payable [Abstract]	'
Summary of fair values of warrants	'
	Assumption	2012
	Expected Volatility		98%-111	%
	Expected term (years)		4-Feb
	Risk-free interest rate		0.74%-2.01	%

Stock_Options_and_Warrants_Tab

Stock Options and Warrants (Tables)	12 Months Ended
Stock Options and Warrants (Tables)	Dec. 31, 2013
Stock Options [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Summary of stock option activity	'
		Options			Weighted Average
		Options			Exercise Price
	Outstanding at December 31, 2011		186,000		$	10.6
	Granted		15,000			10
	Cancelled		(64,000	)		10.05
	Outstanding at December 31, 2012		137,000		$	9.7
	Granted		-			-
	Exercised		-			-
	Cancelled		(32,000	)		10.06
	Forfeited		-			-
	Outstanding at December 31, 2013		105,000		$	11.03
	Exercisable		105,000		$	11.03

Warrant [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Summary of stock option activity	'
					Weighted Average
		Warrants			Exercise Price
	Outstanding at December 31, 2011		7,033,392			13.6
	Granted		665,150			9.55
	Exercised		(1,282,940	)		4.5
	Cancelled		(3,923,518	)		15.5
	Forfeited		(425,000	)		15.2
	Outstanding at December 31, 2012		2,007,083			13.9
	Granted		17,639,700			0.4
	Exercised		(65,050	)		13.26
	Cancelled		(24,750	)		5.56
	Forfeited		-			-
	Outstanding at December 30, 2013		19,556,983		$	3.6
	Exercisable		19,556,983		$	3.6

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
Commitments and Contingencies (Tables)	Dec. 31, 2013
Commitments and Contingencies [Abstract]	'
Schedule of future minimum lease payments	'
	2014	$	82,899
	2015	$	85,256
	2016	$	87,614
	2017	$	89,971
	2018	$	84,634

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2013
Income Taxes [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
		December 31,
		2013			2012
	Net operating losses	$	17,300,000		$	14,700,000
	Less: valuation allowance		(17,300,000	)		(14,700,000	)
	Net deferred tax assets	$	-		$	-

Background_Basis_of_Presentati2

Background, Basis of Presentation (Details) (License Agreement Terms [Member], USD $)	12 Months Ended
	Dec. 31, 2013
2014 [Member]	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'
Royalty Revenue	$25,000
2015 [Member]	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'
Royalty Revenue	40,000
2016 [Member]	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'
Royalty Revenue	50,000
2017 [Member]	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'
Royalty Revenue	65,000
2018 [Member]	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'
Royalty Revenue	75,000
2019 and thereafter [Member]	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'
Royalty Revenue	$100,000

Background_Basis_of_Presentati3

Background, Basis of Presentation (Details Textual) (USD $)

12 Months Ended

1 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 20, 2013

Sep. 24, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Feb. 07, 1994

Sep. 24, 2013

License Agreement [Member]

Going_Concern_Details

Going Concern (Details) (USD $)	12 Months Ended
Going Concern (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Going Concern [Abstract]	'	'
Accumulated deficit	($172,263,028)	($133,024,288)
Working capital deficit	$1,255,222	'

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details)	12 Months Ended
Summary of Significant Accounting Policies (Details)	Dec. 31, 2013
Summary of Significant Accounting Policies (Textual)	'
Property and equipment, depreciation method	'
Property and equipment, depreciation method	Straight-line method
Property and equipment, estimated useful lives	'
Property and equipment, estimated useful lives	Estimated useful lives range from three to eight years.

Related_Party_Convertible_Note1

Related Party Convertible Notes Payable (Details) (USD $)	1 Months Ended	12 Months Ended		239 Months Ended
Related Party Convertible Notes Payable (Details) (USD $)	Sep. 24, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Related party convertible notes payable (Textual)	'	'	'	'
Borrowings from shareholder	'	$6,800,000	$2,130,000	'
Unsecured note interest	5.00%	'	5.00%	'
Unsecured notes conversion price	$2.50	'	'	'
Warrants purchase price	$1	'	'	'
Common shares issued for conversion	6,800,000	115,500	800,000	'
Warrants issued for conversion of notes	6,800,000	'	'	'
Warrants exercisable term	'	'5 years	'	'
Unsecured note, maturity date	31-Dec-13	'	22-Dec-12	'
Converted outstanding notes accrued interest	'	105,000	2,206,278	'
Common shares and warrants issued for debt conversions, share	'	115,500	'	'
Common shares and warrants issued for debt conversions	'	'	289,975	'
Short term related party notes	'	240,000	'	240,000
Short term debt repaid	'	563,800	'	'
Short term debt, due	'	100,000	'	100,000
Due to related parties	'	'	500,000	'
Amortization of debt discounts	'	45,421	3,653,530	12,175,705
Principal repayments on debt	'	1,725,000	300,000	7,475,000
Common Stock [Member]	'	'	'	'
Related party convertible notes payable (Textual)	'	'	'	'
Common shares and warrants issued for debt conversions, share	76,200	'	'	'
Warrant [Member]	'	'	'	'
Related party convertible notes payable (Textual)	'	'	'	'
Common shares and warrants issued for debt conversions, share	76,200	'	'	'
Related Party Notes Payable [Member]	'	'	'	'
Related party convertible notes payable (Textual)	'	'	'	'
Converted outstanding notes accrued interest	'	105,000	'	'
Common shares and warrants issued for debt conversions, share	'	115,500	'	'
Common shares and warrants issued for debt conversions	'	57,915	'	'
Amortization of debt discounts	'	'	2,239,020	'
Principal repayments on debt	'	'	$630,000	'

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)	1 Months Ended	12 Months Ended
Convertible Notes Payable (Details) (USD $)	Sep. 24, 2013	Dec. 31, 2013	Dec. 31, 2012
Converted Notes Payable (Textual)	'	'	'
Short-term debt outstanding	'	'	$4,342,079
Borrowings from investors	'	6,800,000	2,130,000
Unsecured note interest	5.00%	'	5.00%
Unsecured notes conversion price	$2.50	'	'
Warrants exercisable term	'	'5 years	'
Warrants purchase price	$1	'	'
Common shares issued for conversion	6,800,000	115,500	800,000
Warrants issued for conversion of notes	6,800,000	'	'
Debt Instrument, Maturity Date	31-Dec-13	'	22-Dec-12
Convertible Notes Payable [Member]	'	'	'
Converted Notes Payable (Textual)	'	'	'
Short-term debt outstanding	'	2,432,500	'
Convertible Notes Payable [Member] \| UTCH [Member]	'	'	'
Converted Notes Payable (Textual)	'	'	'
Common shares issued for conversion	4,557,000	'	'
Warrants issued for conversion of notes	4,557,000	'	'
Debt Instrument, Maturity Date	31-Dec-13	'	'
Convertible Notes Payable [Member] \| GPEC [Member]	'	'	'
Converted Notes Payable (Textual)	'	'	'
Borrowings from investors	'	$2,124,500	'
Unsecured note interest	5.00%	'	'
Unsecured notes conversion price	$2.50	'	'
Warrants purchase price	$1	'	'

Notes_Payable_Details

Notes Payable (Details)	12 Months Ended
Notes Payable (Details)	Dec. 31, 2012
Assumption	'
Expected Volatility, minimum	98.00%
Expected Volatility, maximum	111.00%
Risk-free interest rate, minimum	0.74%
Risk-free interest rate, maximum	2.01%
Minimum [Member]	'
Assumption	'
Expected term (years)	'2 years
Maximum [Member]	'
Assumption	'
Expected term (years)	'4 years

Notes_Payable_Details_Textual

Notes Payable (Details Textual) (USD $)	1 Months Ended	12 Months Ended		239 Months Ended
Notes Payable (Details Textual) (USD $)	Sep. 24, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Notes Payable (Textual)	'	'	'	'
Common shares and warrants issued for debt conversions	'	'	$289,975	'
Common shares issued for conversion	6,800,000	115,500	800,000	'
Common stock fair value determined	'	2,214,000	'	'
Short-term debt outstanding	'	'	4,342,079	'
Amortization of debt discounts	'	45,421	3,653,530	12,175,705
Company borrowing amount	'	'	2,300,000	'
Debt, interest rate, maximum	'	'	5.00%	'
Debt, interest rate, minimum	'	'	45.00%	'
Vesting period	'	'	'5 years	'
Relative value on warrants and common shares issued	'	'	146,231	'
Unamortized debt discount	'	'	45,369	'
Loss on extinguishment of debt	'	-1,811,800	-2,410,506	-44,836,858
Debt Extensions [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares issued for conversion	'	'	363,500	'
Common stock issued in connection with debt extension	'	286,000	'	'
Amortization of debt discounts	'	'	3,325,000	'
Vesting period	'	'	'5 years	'
Exercise Price Range, maximum	'	'	$12	'
Loss on extinguishment of debt	'	'	2,390,531	'
Common Stock [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares and warrants issued for debt conversions	'	'	3	'
Common shares issued for conversion	'	'	198,000	'
Amortization of debt discounts	'	'	470,433	'
Relative value on warrants and common shares issued	'	'	515,802	'
Common Stock [Member] \| Debt Extensions [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares issued for conversion	'	'	363,500	'
Relative value on warrants and common shares issued	'	'	2,235,525	'
Warrant [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares issued for conversion	'	'	65,500	'
Common stock fair value determined	'	176,819	'	'
Exercise Price Range, minimum	'	'	$0.01	'
Exercise Price Range, maximum	'	'	$2.40	'
Relative value on warrants and common shares issued	'	'	310,732	'
Warrant [Member] \| Debt Extensions [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares issued for conversion	'	'	100,000	'
Relative value on warrants and common shares issued	'	'	155,006	'
Third Party Loans [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Repayment of notes payable	'	1,725,000	'	'
Common shares and warrants issued for debt conversions	'	230,000	'	'
Common shares issued for conversion	'	46,000	'	'
Common stock fair value determined	'	282,900	'	'
Loss on debt extinguishment	'	52,900	'	'
Amortization of debt discounts	'	'	'	'
Notes Payable [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares and warrants issued for debt conversions	'	'	270,000	'
Common stock fair value determined	'	1,758,900	'	'
Short-term debt outstanding	'	1,400,000	'	1,400,000
Common stock issued in connection with debt extension	'	286,000	'	'
Amortization of debt discounts	'	45,421	'	'
Loss on extinguishment of debt	'	'	$19,975	'
Notes Payable [Member] \| Common Stock [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares issued for conversion	'	'	31,500	'
Notes Payable [Member] \| Warrant [Member]	'	'	'	'
Notes Payable (Textual)	'	'	'	'
Common shares issued for conversion	'	'	25,000	'

Stock_Options_and_Warrants_Det

Stock Options and Warrants (Details) (USD $)	12 Months Ended
Stock Options and Warrants (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'
Number of Shares, Outstanding	'	137,000
Weighted Average Exercise Price, Outstanding	'	$9.70
Stock Options [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'
Number of Shares, Outstanding	137,000	186,000
Number of shares, granted	'	15,000
Number of Shares, Exercised	'	'
Number of Shares, Cancelled	-32,000	-64,000
Number of Shares, Forfeited	'	'
Number of Shares, Outstanding	105,000	137,000
Number of Shares, Exercised	105,000	'
Weighted Average Exercise Price, Outstanding	$9.70	$10.60
Weighted Average Exercise Price, Granted	'	$10
Weighted Average Exercise Price, Exercised	'	'
Weighted Average Exercise Price, Cancelled	$10.06	$10.05
Weighted Average Exercise Price, Forfeited	'	'
Weighted Average Exercise Price, Outstanding	$11.03	$9.70
Weighted Average Exercise Price, Exercisable	$11.03	'
Warrant [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'
Number of Shares, Outstanding	2,007,083	7,033,392
Number of shares, granted	17,639,700	665,150
Number of Shares, Exercised	-65,050	-1,282,940
Number of Shares, Cancelled	-24,750	-3,923,518
Number of Shares, Forfeited	'	-425,000
Number of Shares, Outstanding	19,556,983	2,007,083
Number of Shares, Exercised	19,556,983	'
Weighted Average Exercise Price, Outstanding	$13.90	$13.60
Weighted Average Exercise Price, Granted	$0.40	$9.55
Weighted Average Exercise Price, Exercised	$13.26	$4.50
Weighted Average Exercise Price, Cancelled	$5.56	$15.50
Weighted Average Exercise Price, Forfeited	'	$15.20
Weighted Average Exercise Price, Outstanding	$3.60	$13.90
Weighted Average Exercise Price, Exercisable	$3.60	'

Stock_Options_and_Warrants_Det1

Stock Options and Warrants (Details Textual) (USD $)	12 Months Ended
Stock Options and Warrants (Details Textual) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Stock Options And Warrants (Textual)	'	'
Number of options to purchase common stock	2,000,000	'
Common shares issued for services, share	15,000	'
Common shares issued for services	$25,971,940	'
Vesting period	'	'5 years
Warrants granted during the period	'	21,060
Stock Options [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Weighted average remaining contractual life of options outstanding	'2 years 7 months 6 days	'1 year 11 months 9 days
Exercise price of options/warrants	'	10
Intrinsic value of the options/warrants	0	0
Common shares issued for services, share	'	15,000
Common shares issued for services	'	82,312
Vesting period	'	'10 years
Number of Shares, Forfeited	'	'
Stock Options [Member] \| Minimum [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Exercise price of options/warrants	$10	10
Stock Options [Member] \| Maximum [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Exercise price of options/warrants	$15	15
Warrant [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Weighted average remaining contractual life of options outstanding	'4 years 8 months 19 days	'14 years
Warrants exercised	65,050	'
Proceeds from warrants exercised	176,819	'
Intrinsic value of the options/warrants	0	0
Number of Shares, Forfeited	'	-425,000
Conversion of warrants to common shares during the period	'	3,053,958
Warrant [Member] \| Minimum [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Exercise price of options/warrants	$0.05	17.5
Warrant [Member] \| Maximum [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Exercise price of options/warrants	$17.50	0.05
Warrant [Member] \| Exercise Price Range One [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Common shares issued for services, share	'	83,400
Common shares issued for services	'	465,533
Warrant [Member] \| Exercise Price Range One [Member] \| Minimum [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Exercise price of options/warrants	'	5
Vesting period	'	'5 years
Warrant [Member] \| Exercise Price Range One [Member] \| Maximum [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Exercise price of options/warrants	'	12
Vesting period	'	'10 years
Warrant [Member] \| Exercise Price Range Two [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Exercise price of options/warrants	'	12
Common shares issued for services	'	57,173
Vesting period	'	'5 years
Warrants granted during the period	'	23,400
Common shares [Member]	'	'
Stock Options And Warrants (Textual)	'	'
Conversion of warrants to common shares during the period	'	463,397

Common_Stock_Details

Common Stock (Details) (USD $)

12 Months Ended

179 Months Ended

1 Months Ended

12 Months Ended

179 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Sep. 22, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

UTCH [Member]

Warrant [Member]

Common Stock [Member]

Common Stocks Textual [Abstract]

Common shares issued for warrant exercise, share

60,070

1,282,940

30,000

10,000

598,125

Common shares issued for warrant exercise

$176,819

$1,515,529

$1,500

$25,000

$1,170,150

$128

$60

Common shares issued for services, share

15,000

2,858,811

Common shares issued for services

25,971,940

286

Common shares issued for loan extensions, Share

286,000

363,500

Common shares issued for loan extensions

1,758,900

2,235,561

Common shares issued to debt holders for additional interest, share

173,552

Common shares issued to debt holders for additional interest

1,067,345

Common shares issued for default penalty interest, share

360,000

Common shares issued for default penalty interest

2,214,000

Common shares issued to warrant holders for additional interest, share

119,300

Common shares issued to warrant holders for additional interest

733,695

Common shares issued for consulting services, share

15,000

Common shares issued for consulting services

92,250

Common shares issued for debt conversion, shares

46,000

4,400,000

Common shares issued for debt conversion

282,900

4,000,000

440

Common shares issued for cash, shares

1,155,000

110,000

272,000

Common stock issued for cash

1,050,000

100,000

1,370,000

116

Shares issued price per share

$0.91

Common shares issued for forgiveness of debt, share

115,500

Common shares issued for forgiveness of debt

162,915

Common shares issued for warrant exchange, shares

74,400

463,397

Conversion of warrants to common shares during the period

3,053,958

Converted note interest due amount

105,000

Common Stock, Shares, Outstanding

42,799,278

16,091,909

9,658,936

12,000,000

Common Stock, shares issued

42,799,278

16,091,909

9,658,936

Common stock, shares cancelled

9,000,000

-425,000

Common shares and warrants issued for debt conversions, share

115,500

31,500

Common shares issued with party debt, shares

198,000

Common shares issued with related debt, shares

800,000

Sale of stock and warrant, description

'Each unit consisted of one common share and one warrant.

Sale of common shares and warrants in PPM

532,500

428,500

2,438,602

100,000

Sale of common shares and warrants in PPM, shares

426,000

43,250

270,000

10,000

Sale of stock and warrant, per share price

$1.25

$10

Forward split

'1.2-for-1

Common Stock, par value per share

$0.00

Changes in Capital Structure

'Authorized and issued common stock increased from 8,049,113 to 9,658,936.

Distribution to shareholders for return on equity investment

130,000

Equity investment from shareholders

225,000

Warrant exercisable period

'5 years

Warrants exercisable price per share

2.5

Warrants issued for services

9,402,381

1,111,571

6,538,628

300

Warrants issued for services, shares

2,988,500

Relative fair value of warrants

$146,231

$310,732

$515,802

Share issued to officers as compensation vesting, description

'The Company issued an aggregate of 2,988,500 to officers as compensation of which 2,110,000 have the following vesting terms, 1/4 immediately upon issuance, 1/4 will be released upon one year from the effective date, and 1/4 will be released upon two years, the last 1/4 will be released after three years completion from the effective date.

Shaes issued to officers as compensation vests immediately

878,500

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2013
Schedule of future minimum lease payments	'
2014	$82,899
2015	85,256
2016	87,614
2017	89,971
2018	$84,634

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended
Commitments and Contingencies (Details Textual) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies (Textual)	'	'
Rent expense	$4,476	$15,608
Lease agreement [Member]	'	'
Commitments and Contingencies (Textual)	'	'
Rent expense	$3,689	'
Term of lease agreement	'60 months	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Components of Deferred Tax Assets and Liabilities [Abstract]	'	'
Net operating losses	$17,300,000	$14,700,000
Less: valuation allowance	-17,300,000	-14,700,000
Net deferred tax assets	'	'

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
Income Taxes (Details Textual) (USD $)	Dec. 31, 2013
Income Taxes (Textual)	'
Net operating loss carry forwards	$51,000,000
Expiration period	31-Dec-16

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	12 Months Ended
Subsequent Events (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Subsequent Events (Textual)	'	'
Number of units sold	426,000	43,250
Sale of stock and warrant, per share price	$1.25	$10
Sale of units of common share and warrants, amount	$532,500	$428,500
Warrants exercisable term	'5 years	'
Subsequent Event [Member]	'	'
Subsequent Events (Textual)	'	'
Number of units sold	112	'
Sale of stock and warrant, per share price	$1.25	'
Sale of units of common share and warrants, amount	$140,000	'
Warrants exercisable term	'5 years	'
Warrants issued price per share	$2.50	'